key: cord-0863535-kpssj6wx authors: Albert, Elisabeth; Aurigemma, Gerard; Saucedo, Jason; Gerson, David S. title: Myocarditis following COVID-19 vaccination date: 2021-05-18 journal: Radiol Case Rep DOI: 10.1016/j.radcr.2021.05.033 sha: d545b79a2256894577445fb6ed47d38f43cf3353 doc_id: 863535 cord_uid: kpssj6wx nan The coronavirus disease 2019 (COVID-19) vaccination frequently leads to minor sideeffects, that may be more intense after the second dose, but more serious side effects have been reported. We report a case of a 24-year-old man who presented to the hospital with acute substernal chest pain, 4 days after his second COVID-19 Moderna vaccination. Laboratory studies revealed elevated troponins and negative viral serologies. Cardiac magnetic resonance imaging (cMRI) demonstrated edema and delayed gadolinium enhancement of the left ventricle in a midmyocardial and epicardial distribution. The patient was diagnosed with myocarditis following Moderna vaccination. Our case report raises concern that myocarditis is a rare side effect of COVID-19 vaccine. Despite our report, it appears that there is a significantly higher risk of cardiac involvement from COVID-19 infection compared to COVID-19 vaccination. A previously healthy 24-year-old man, with no past cardiac medical history, presented to emergency department with chest discomfort 4-days after his second dose of the Moderna COVID19 vaccine. Initially the patient experienced a subjective fevers, chills, and body aches in the first 24 hours after the shot. His symptoms progressed to a substernal chest pain, which was exacerbated with deep inspiration and supine position. The patient reported similar symptoms after the first vaccine administration, but these symptoms were not nearly as intense. The patient's electrocardiogram demonstrated a sinus rhythm without ischemic changes. Laboratory studies revealed: elevated troponin I (18.94ng/mL, normal 0.01-0.04), elevated Creatine Kinase (704 U/L, normal 49-348), elevated C Reactive Protein (26.4 mg/L, normal <10.0) and negative PCR for COVID-19. Viral studies, including Parvovirus B19, Ebstein-Barr virus, adenovirus, influenza, Herpes Simplex 1 and 2, Lyme antibody were all negative. A Transthoracic echocardiogram 4 days post vaccination was within normal limits, the left ventricular ejection fraction (LVEF) was 65%. No focal wall motion abnormality was seen. Computed tomographic angiography of the coronary arterial system 5 days postvaccination demonstrated a calcium score of 0 without coronary artery stenosis and small bilateral pleural effusions. Cardiac MRI with gadolinium 5 days post-vaccination demonstrated normal LV size and EF (58%), patchy mid-myocardial and epicardial delayed gadolinium enhancement ( Fig.1) , with superimposed edema (Fig.1) , fulfilling the Lake Louise criteria for myocarditis Vaccination is a well-established part of preventive and public health medicine, but is not without risk. COVID-19 vaccination frequently leads to minor side-effects, for example pain, swelling and redness at the site of injection, and systemic symptoms of fatigue, headache, muscle pain, chills and fever; side effects after the second dose may be more intense than the first dose [1] . Among the mRNA vaccines, including Pfizer-BioNTech and Moderna, more serious side effects have been reported, including myocarditis [2, 3] . Myocarditis can range from mild asymptomatic inflammation of the heart to severe heart failure and death [4] . Viral infection has been described as one of the most common causes of myocarditis, especially associated with influenza and parvovirus B-19 infection. Myocarditis has been reported following many different vaccines, with the smallpox vaccine having the strongest association [5] . At time of writing, neither the FDA nor CDC have reported any safety signals for myocarditis following the administration of the approved COVID-19 vaccines [6] . At present time, there are no reports in the scientific literature reporting notion of myocarditis related to COVID-19 vaccination. There are specific indications for cardiac MRI in suspected myocarditis case including currently symptomatic cases, evidence of myocardial damage and suspected viral or autoimmune etiologies [7, 8] . The diagnosis of myocarditis can be confirmed by cardiac MRI. Two criteria have been developedthe Original and the 2018 Lake Louise Criteria for the diagnosis of acute myocarditis. In the original criteria, two out of three elements are needed for diagnosis. The three elements are: (1) regional or global myocardial signal intensity increase on T2-weighted images; (2) increased global myocardial early gadolinium enhancement ratio; (3) at least one focal, nonischemic lesion at late gadolinium enhancement. In the revised 2018 Lake Louise criteria, both (1) regional or global myocardial signal intensity and relaxation time increase on T2-weighted images and (2) increase native relaxation time and extracellular volume on T1-weighted images and nonischemic pattern late gadolinium enhancement are needed [7, 8] . In summary, we recognize that vaccination is one of the greatest advancement in medicine in the previous century, and has significantly reduced the burden of infectious disease [9] . From Louis Pasteur, who developed the first laboratory vaccine in 1879, for chicken cholera [10] , to the 21st century COVID-19 pandemic, untold disability and death has been prevented by vaccination [9] . Despite the demonstration of safety, and the endorsement of the World Health Organization, and other bodies that vaccines are far safer than therapeutic drugs, vaccines are not without risk [9] . Myocarditis is one of the serious adverse event of vaccination [5] . We believe that given the negative PCR test for COVID-19, as well as the negative viral serologies, myocarditis, in this instance, was due to the vaccine, rather than acute infection, but the latter possibility cannot be totally discounted. The mechanisms involved in such vaccine-related myocarditis are not clear as of this writing [11] . The patient has been discharged from hospital with beta-blocker medication. He was instructed to avoid strenuous activities for three months, as well as non-steroidal antiinflammatory drugs (NSAID). The patient has a scheduled follow-up appointment with the cardiologist. Despite the fact that myocarditis has been reported following many vaccines [5] , further research will be needed to confirm the association of myocarditis post-COVID-19 vaccination. The data in hand suggest a small risk of myocarditis following infection [7, 8, 12] , as well as thrombosis related myocardial infarction [13] . Thus despite our report, it appears that there is a significantly higher risk of cardiac involvement from COVID-19 infection compared to COVID-19 vaccination [12] . Accordingly, we believe that COVID-19 vaccination should remain the cornerstone for population immunity. Written, informed consent for publication of his case was obtained from the patient. written consent is retained by the authors. A. C . D. E. F. Center for Disease Control and Prevention Possible Side Effects After Getting a COVID-19 Vaccine s_cid=10509:side%20effects%20of%20covid%2019%20vaccine: sem.ga:p :RG:GM:gen:PTN:FY21 Lee Are rare cases of myocarditis linked to Pfizer, Moderna Covid-19 vaccines? Forbes Toi Staff Israel said probing link between Pfizer shot and heart problem in men under 30 The Times of Israel Myocarditis secondary to smallpox vaccination FDA see no Pfizer vaccine link to heart problem, eyeing with 'special interest' McClatchy Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper Consensus criteria for the diagnosis of myocarditis Vaccination greatly reduces disease, disability, death and inequity worldwide Bulletin of the World Health Organization The College of Physicians of Philadelphia The history of Vaccines Consulted on Acute fulminant myocarditis following influenza vaccination requiring extracorporeal membrane oxygenation Acute Crit Care COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Hunter P Thrombosis after Covid-19 vaccination